Concepedia
Statistics
Publications
7
Citations
388
H-Index
Active since
1995
Affiliations
Pfizer (United States)(Current)
Mercy Medical Center
Erling O. Emerson is an author at Pfizer (United States) specializing in pharmacology, medicine, and molecular oncology.
Publications per year
1995–2010
Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
Jean S. Beebe, Jitesh P. Jani, Elisabeth Knauth et al. · PubMed · 2003 · 128 citations
Medicine, Oncology, Pharmacology +16
PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
Jitesh P. Jani, Joel T. Arcari, Vincent Bernardo et al. · Molecular Cancer Therapeutics · 2010 · 89 citations
Medicine, Oncology, Pharmacology +12
Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor
Jitesh P. Jani, Richard S. Finn, Mary E. Campbell et al. · Cancer Research · 2007 · 76 citations · Full text
Medicine, Oncology, Pharmacology +17
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.
Elsa G. Barbacci, Leslie R. Pustilnik, Ann Marie Rossi et al. · PubMed · 2003 · 46 citations
Medicine, Cancer Biology, Pharmacology +17
Mechanism of cross‐resistance to cisplatin in a mitomycin C‐resistant human bladder cancer cell line
Shivendra V. Singh, Bing Xu, Jitesh P. Jani et al. · International Journal of Cancer · 1995 · 20 citations
1–5 of 7